Tevogen Bio Holdings Inc. (NasdaqGM:TVGN) (?Tevogen? or ?Tevogen Bio?) released a letter to stockholders highlighting recent achievements, growth plans, and consideration of a potential share buyback. In light of recent stock performance, we understand the concerns some of you may have regarding Tevogen Bio?s current share price.

We are acutely aware of the situation and our commitment to improving stockholder value remains steadfast. We are considering available options, including the potential for a share repurchase, to enhance the value of your investment. ?We remain committed to transparency and open communication with our stockholders.

We believe that our ongoing efforts and strategic initiatives will position Tevogen Bio for sustained growth and success. Thank you for your continued trust and support,? commented Ryan Saadi, MD, MPH, Founder and CEO, Tevogen Bio.